FDA Investigator Yideng Liang
Yideng Liang has conducted inspections on 1 sites in 1 countries as of 10 Feb 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
1
Last Inspection Date:
10 Feb 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Yideng Liang:
Andrew "Drew" Haack, PhD,
Andrew K Haack, PhD,
Anita Narula, PhD,
Arie C Menachem,
Barbara Janine Breithaupt,
Brian M Janelsins, PhD,
CDR Donald Ertel,
Charles Yuanchia Kuo, PhD,
Chava Kimchi Sarfaty, PhD,
Christopher R Czajka,
Colleen F Hoyt,
Deborah M Trout,
Joan Johnson,
Kathryn E King,
Lisa K Capron,
Michael S Araneta,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Nataniel Phillips Sylvain, PhD,
Prabhu P Raju,
Rabia Ballica, PhD,
Richard Ledwidge (nmi), PhD,
Riley C Myers, PhD,
S Lori Brown, PhD MPH,
Teegan Dellibovi Ragheb, PhD,
Thuy T Nguyen, LCDR,
V Teres Speer,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Wayne E Seifert,
Yuan Chia Kuo,
Zhong Li, PhD
Yideng Liang's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2016 | FDA 483 | AGC Biologics, Inc. - Form 483, 2016-04-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more